Healwell AI Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- James Samuel Lee
- Full Time Employees
- 570
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 4881 Yonge Street Toronto ON Canada M6G 1A1
- IPO Date
- Dec 21, 2021
- CIK
- 0001999124
- Website
- healwell.ai
- Similar Companies
- Business
- Healwell AI Inc. (HWAIF) operates as a healthcare technology company specializing in artificial intelligence and data science solutions for preventative care, with a mission to improve healthcare outcomes through early disease detection and clinical decision support. The company develops and deploys proprietary AI clinical co-pilot platforms that screen for hundreds of rare, complex, and chronic diseases, including Gaucher disease, Chronic Kidney Disease, and Neovascular Age-Related Macular Degeneration (nAMD); it offers AI-driven early disease detection tools, clinical decision support systems, healthcare data analytics, electronic health records (EHR) software, pulmonary function testing, clinical research services, telehealth and virtual care platforms, and healthcare interoperability software. Healwell AI conducts its operations through three segments—Clinical Research and Patient Services, AI and Data Sciences, and Healthcare Software—serving healthcare providers, health systems, public sector entities, and life sciences organizations primarily in Canada with expanding global reach. Founded in 2012 and headquartered at 460 College Street, Unit 301, Toronto, Ontario, Canada, the company benefits from an exclusive strategic partnership with WELL Health Technologies Corp., its largest investor, providing access to over 40,000 clinicians and more than 5 million annual patient interactions across Canada's leading digital healthcare ecosystem. In recent developments, Healwell AI acquired a 51% controlling interest in Mutuo Health Solutions on November 1, 2024, to enhance its medical AI capabilities; made a USD$250,000 strategic investment in Abstractive Health on October 22, 2024, for generative AI-powered clinical documentation; completed the acquisition of Orion Health Holdings Limited in 2025, funded by a $55 million bought-deal financing and up to $50 million in senior debt, to create a global leader in AI-integrated healthcare software including Amadeus and Virtuoso platforms; and announced strategic divestments of non-core businesses on November 3, 2025, including clinical research units and the Mutuo SMB business, to transition into a pure-play SaaS, services, and AI enterprise focused on high-margin global health systems.
Company News
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026
HEALWELL AI Announces Conference Call for Second Quarter 2026 Financial Results on August 7, 2026
HEALWELL AI Announces Voting Results of 2026 AGSM
HEALWELL AI Provides Corporate Update: Multi-Province AI Pilot Results Accepted at AMIA Symposium; Alongside Balance Sheet Strengthening with SpaceX Holdings
Healwell AI Inc. (AIDX:CA) Q1 2026 Earnings Call Transcript
HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026
HEALWELL AI Announces Conference Call for First Quarter 2026 Financial Results on May 8, 2026
HEALWELL AI Appoints Brad Porter to Board of Directors
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Healwell AI Inc. (AIDX:CA) Q4 2025 Earnings Call Transcript
HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold
HEALWELL AI Reaches 47 Peer-Reviewed Publications, Strengthening Its Scientific Moat for AI-Powered Real-World Clinical Evidence Generation
HEALWELL AI to Announce Fourth Quarter and Year End 2025 Financial Results on March 19, 2026
HEALWELL AI Announces Multi-Million Dollar U.S. Health Information Exchange Contract and AI-Driven Pipeline Momentum
HEALWELL to Participate in Upcoming TD Cowen, Scotiabank and ROTH Investor Conferences
HEALWELL AI Expands Global Footprint with First AI Implementation in Middle East and Growing Enterprise Adoption Across Canada and the United States
WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research
HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research